InMode has a strong competitive position in the rapidly growing global aesthetic market with its innovative products and technology. The company has achieved impressive financial performance with ...

Medical devices company InMode (NASDAQ:INMD) has fallen out of favor with investors in the past two years for various reasons, which we'll explain below. However, now that it's down 76% from highs, ...

Despite a highly profitable business model and a strong position in the medical aesthetics industry, INMD stock is down -33% over the last 12 months. Macroeconomic pressures, political risks in InMode ...

Shares of InMode (NASDAQ: INMD), a medical technology company focused on the aesthetics industry, recently reached a new 52-week high in anticipation of the second-quarter earnings report the company ...

Investing in stocks inevitably means buying into some companies that perform poorly. Long term InMode Ltd. (NASDAQ:INMD) shareholders know that all too well, since the share price is down considerably ...

Inmode ((INMD)) has held its Q3 earnings call. Read on for the main highlights of the call. InMode’s recent earnings call revealed a mixed sentiment, with positive developments in international ...

InMode Ltd. (NASDAQ:INMD) Q2 2025 Earnings Call Transcript July 30, 2025 InMode Ltd. beats earnings expectations. Reported EPS is $0.47, expectations were $0.43. Operator: Good day, and welcome to ...

InMode Ltd INMD reported Q2 sales of $136.1 million, an increase of 20% Y/Y, beating the consensus of $132 million and slightly above the preliminary numbers. Adjusted EPS reached $0.72, compared to ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

InMode shares rose sharply in anticipation of the company's second-quarter earnings report. Soaring sales of medical devices used for minimally invasive cosmetic procedures drove profits 25% higher ...